In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page

MEB 48: a national informed consent marketing authorization application

by In2Pharma | May 9, 2017 | News

MEB The Medicines Evaluation Board (MEB) introduced MEB 48, a new policy concerning the application of marketing authorizations for medicines that are identical to medicines already authorized. For this, a national informed consent marketing authorization application...

Recent Posts

  • Introduction to FAMHP portal – manufacturing inspections
  • RD export 19/01/2023 – mandatory application for export
  • Fiscal importation of medicines from 3rd countries
  • NARCOTIC/PSYCHOTROPIC LEGISLATION: important clarifications concerning the narcotic order forms
  • Negative formulations no longer allowed on packaging of medicinal products for human use

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België